Selective silencing of DNA-specific B lymphocytes delays lupus activity in MRL/lpr mice. [electronic resource]
Producer: 20080228Description: 3587-96 p. digitalISSN:- 0014-2980
- Animals
- Antibodies, Antinuclear -- biosynthesis
- Antibodies, Monoclonal -- therapeutic use
- Antibody Specificity
- Apoptosis -- drug effects
- B-Lymphocyte Subsets -- drug effects
- Cells, Cultured -- immunology
- Cross-Linking Reagents -- pharmacology
- DNA -- immunology
- Diphtheria Toxoid -- immunology
- Disease Models, Animal
- Female
- Immunoconjugates -- therapeutic use
- Immunoglobulin G -- biosynthesis
- Immunosuppressive Agents -- therapeutic use
- Lupus Erythematosus, Systemic -- genetics
- Mice
- Mice, Inbred MRL lpr
- Molecular Mimicry
- Oligopeptides -- administration & dosage
- Receptors, Antigen, B-Cell -- drug effects
- Receptors, IgG -- drug effects
- Recombinant Fusion Proteins -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.